Skip to main content

Well-Being, Psychological

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Enterprise Therapeutics
1 program
SEE Change Business and Personal Agency TrainingN/A1 trial
Active Trials
NCT05958225Completed814Est. Oct 2024
ICU Medical
ICU MedicalCA - San Clemente
1 program
The procedure of protective lung ventilationN/A1 trial
Active Trials
NCT06282003Unknown53Est. Sep 2024

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
ICU MedicalThe procedure of protective lung ventilation
Enterprise TherapeuticsSEE Change Business and Personal Agency Training

Clinical Trials (2)

Total enrollment: 867 patients across 2 trials

NCT06282003ICU MedicalThe procedure of protective lung ventilation

Protective Anesthesiological Management Procedure Imposes Control on Respiratory Comlications

Start: Oct 2023Est. completion: Sep 202453 patients
N/AUnknown
NCT05958225Enterprise TherapeuticsSEE Change Business and Personal Agency Training

SEE Change Evaluation - Impacts of Personal Agency Training on Ugandan Entrepreneurs

Start: Sep 2023Est. completion: Oct 2024814 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.